International bd associate – global pharma trading
Sowaka Health • mumbai, maharashtra • Posted June 26, 2026
About the Role
About the Company
Sowaka Health is building the first compliance‑native platform for named‑patient and early access programs in India and underserved markets globally. Through our proprietary platform, Sowaka OS , we operate specialty access and named‑patient programs for unapproved and hard‑to‑access medicines, working with hospitals, physicians, and global suppliers to create safe, audit‑ready “port‑to‑patient” pathways. In markets where patients needing pre‑commercial or unlicensed breakthrough therapies have limited structured, credible access routes, we are creating that pathway from the ground up with the intent to make it the global standard.
Role purpose
The International BD Associate – Global Pharma Trading is an India‑based commercial operations and business‑development support role responsible for helping identify, qualify, track, and coordinate global patient supply and specialty‑access opportunities, with a strong focus on pharmaceutical cross‑border trading.
T...
Sowaka Health is building the first compliance‑native platform for named‑patient and early access programs in India and underserved markets globally. Through our proprietary platform, Sowaka OS , we operate specialty access and named‑patient programs for unapproved and hard‑to‑access medicines, working with hospitals, physicians, and global suppliers to create safe, audit‑ready “port‑to‑patient” pathways. In markets where patients needing pre‑commercial or unlicensed breakthrough therapies have limited structured, credible access routes, we are creating that pathway from the ground up with the intent to make it the global standard.
Role purpose
The International BD Associate – Global Pharma Trading is an India‑based commercial operations and business‑development support role responsible for helping identify, qualify, track, and coordinate global patient supply and specialty‑access opportunities, with a strong focus on pharmaceutical cross‑border trading.
T...